Diabetes and the QT interval: time for debate
|
|
- Miranda Stanley
- 5 years ago
- Views:
Transcription
1 Diabetes and the QT interval: time for debate RAJEEV KUMAR, 1 MILES FISHER, 2 PETER W MACFARLANE 3 Abstract The electrocardiographic QT interval has been extensively studied in ischaemic heart disease. Recently, there has been increasing interest in the relationship between diabetes and QT abnormalities. QT prolongation and increased QTd have been shown to predict cardiac death in both type 1 and type 2 diabetes mellitus. Although there is general agreement that QT interval is affected by cardiac ischaemia, the effect of hyperglycaemia on QT measures is controversial. There are also problems surrounding QTd. First, there is controversy as to whether the measure has any physiological meaning; secondly, there is no universally accepted method of measurement and hence no consensus about the upper limit of normal. Nevertheless, several studies have shown increased QTd in diabetic patients suggesting that assessment of the QT interval could be a cost effective way of stratifying such patients according to cardiovascular risk so that aggressive treatment could be directed appropriately to improve outcome. Br J Diabetes Vasc Dis 2004;4: Key words: diabetes mellitus, QT prolongation, QT dispersion. Introduction Patients with diabetes mellitus are at an increased risk of dying from cardiovascular diseases, the reason for which is not completely understood. Excess cardiovascular risk in this population persists even after normalisation for other conventional cardiovascular risk factors (hypertension, dyslipidaemia, physical inactivity, smoking) suggesting that there are other incompletely understood mechanisms which increase cardiovascular risk in diabetic patients. Ventricular instability, as manifested in QT abnormalities, might be an important additional mechanism. 1 QE2 Hospital, Welwyn Garden City, AL7 4HQ, UK. 2 Department of Diabetes, Glasgow Royal Infirmary, Glasgow, G4 0SF, UK. 3 University of Glasgow, Division of Cardiovascular and Medical Sciences, Royal Infirmary, Glasgow, G31 2ER, UK. Correspondence to: Dr Rajeev Kumar Department of Diabetes and Endocrinology, QE2 Hospital, Welwyn Garden City, AL7 4HQ, UK. Tel: +44 (0) ; Fax: +44 (0) rajeevsr@hotmail.com What are QT abnormalities The QT interval, which is easily obtained from a standard resting ECG, reflects the total duration of ventricular myocardial depolarisation and repolarisation. It can be corrected for heart rate by using a variety of formulae. The QTc effectively is the QT interval estimated at a rate of 60/minute. A commonly used correction formula is that of Bazett 1 where QTc=QT RR interval. The Bazett formula, which has been heavily criticised, in fact gives a slight over correction of QT interval at higher heart rates while the formula of Hodges et al. 2 (QTc=QT [rate - 60]) has been shown to perform much better and is gradually gaining more widespread acceptance. 3 There are, however, very many QT correction formulae, a detailed discussion of which is beyond the scope of this article. QTc prolongation is a risk factor for sudden death independent of age. 4 The relationship between prolonged QT interval and an increased risk of sudden death has been extensively studied in ischaemic heart disease 5 and a relative risk of 2 5 has been reported. The long QT syndrome is associated with a very high risk of ventricular fibrillation 6 and drugs such as quinidine that prolong the QT interval may also cause sudden arrhythmic death. Formulae Corrected QT interval (QTc) - Bazett 1920 QTc = QT/ RR interval - Hodges et al QTc = QT (rate - 60) QT dispersion (QTd) - On a 12 lead ECG QTd = QT max - QT min QTd is defined as the difference between the maximum and minimum QT interval on the 12 lead ECG (QTd = QT max - QT min). A single QT interval on the surface ECG does not give any information on dispersion of recovery time (i.e. repolarisation) but QTd is said to reflect spatial differences in myocardial recovery time. 7 Healthy subjects exhibit a small degree of QTd. 8 Increased QTd has been observed in chronic heart failure, 9 peripheral vascular disease, 10 hypertension, 11 hypertrophic cardiomyopathy 12 and in CHD, 13 and has been correlated with increased risk of cardiovascular death in these conditions and in healthy subjects. 14 Increased QTd after acute MI is a risk factor for sudden death and QTd has been shown to decrease after successful thrombolytic therapy. 15 It is, therefore, believed that QTd following an acute MI depends not only on infarct site and size but also on reperfusion status. 146 THE BRITISH JOURNAL OF DIABETES AND VASCULAR DISEASE
2 Abbreviations CHD ECG HbA 1C MI QTc QTd coronary heart disease electrocardiogram haemoglobin A 1C myocardial infarction corrected QT interval QT dispersion Increased QTd may indicate non-uniform ventricular repolarisation, thus possibly providing a substrate for the development of malignant ventricular arrhythmias. Endocardial monophasic action potential studies have demonstrated that there are regional differences in the duration of myocardial repolarisation that may be reflected in the surface ECG. 16 Homogeneity of ventricular recovery time is believed to protect against arrhythmias. QTd can be corrected for heart rate but it has been argued that this should not be done. 17 In any event, with a linear correction formula, e.g. the Hodges et al., 1983 formula, 2 there is no need for QTd rate correction, i.e. QTd is the same before and after correcting for rate with this formula. 8 QTc > 440 ms (0.44s) is universally considered as prolonged, although there are small gender based differences. There is still some confusion about the upper limit of normal QTd. QTd > 80 ms (0.08s) is usually considered as abnormally prolonged. 18,19 However, on the basis of a study of over 3,000 neonates, children and adults, an upper limit for normal QTd of 50 ms was suggested by Macfarlane et al. 8 The main problem with QT interval assessment is that there is no universally recognised standard method of analysis or of lead selection. It may not be possible to measure QT interval in every lead, and measurement may be less than precise. QT interval can be measured erroneously by misinterpreting either the beginning of the QRS complex or the end of the T wave. Methodology for determining QTd varies between studies. It can be measured manually, by digitisers, photocopy enlargement of an ECG, and by special computer software. There is an urgent need for standardisation of lead selection and method of measurement. The intra- and inter-observer reproducibility of QTd is low (and significantly lower than that of QT interval) and has been shown to vary 20 and the results, therefore, may not be fully comparable between studies. Some authors have raised doubts about the meaning of QTd. It has been suggested that QTd is unlikely to reflect any aspect of myocardial repolarisation and that it results mainly from the variations in T loop morphology and QT measurement error. 21,22 Why QT in diabetes? Recently there has been growing interest in the relationship between diabetes and QTc and QTd. Prevalence of prolonged QT interval and increased QTd is higher in people with type 1 and type 2 diabetes as compared to non-diabetic subjects, 18,19,23 especially in the presence of autonomic neuropathy. 24 The prevalence of QT prolongation has been reported to be as high as 16% in type 1 diabetes (11% in males and 21% in female patients) 23 and 26% in type 2 diabetes, 19 while that of increased QTd has been reported as 7% in type 1 diabetes (8% in men and 5% in women) 18 and 33% in type 2 diabetes. 19 No association between QT abnormalities and gender has been observed in type 2 diabetes. 19,25 Diabetic patients with more pronounced QT abnormalities tend to have higher age and blood pressure and they tend to have cardiovascular complications. 18,19 However, even patients with a recent diagnosis of diabetes and without overt cardiac complications have been observed to have increased QTd compared to non-diabetic subjects. 25 QT interval is affected by CHD and autonomic neuropathy and it is possible that these new diabetic patients with prolonged QT interval and increased QTd may have had undiagnosed neuropathy or CHD. Prolonged QTc and increased QTd are independent markers for CHD in type 1 and type 2 diabetes 18,19 and have been demonstrated to be highly significant predictors of cardiac death 26 even in newly diagnosed type 2 diabetes. 27 Comparison between QTd and microalbuminuria suggests that increased QT dispersion is a better predictor of cardiac death in patients with diabetes. 26 QTd > 78 ms after six years of diabetes predicted cardiac death with 100% sensitivity and 90% specificity i.e. an odds ratio of nine, 27 compared with an odds ratio of 1.8 for microalbuminuria (95% CI, ) in an overview. 28 No association has been found between QTd and microvascular diabetic complications. 18,19,25 QT interval and autonomic neuropathy Cardiac autonomic neuropathy is a well-recognised complication of diabetes and is believed to be responsible for an increased risk of sudden death. Ewing s battery of tests 29 remains too cumbersome for use in routine clinical practice. Consensus statements released by the American Diabetic Association and the American Academy of Neurology indicate that testing for prolongation of Bazett's heart rate-qtc is easy and specific for diabetic cardiac autonomic failure. 30 QTc, however, is seldom used to evaluate alteration in cardiac sympathetic innervation in the clinical setting because of its insensitivity for autonomic failure. A meta-analysis recently concluded that measurement of QTc is a more accurate test for autonomic failure in young men with diabetes and that QTc rules out autonomic failure best among diabetic patients in whom it is most sensitive (i.e. men and young people). 31 In a recent study among patients with type 1 diabetes, QTc did not correlate with the severity of autonomic neuropathy as indicated by other cardiovascular autonomic tests. 32 Thus, there is general agreement that the presence of cardiac autonomic dysfunction increases the duration of the QT interval but it is still controversial as to whether or not it influences QTd. Most studies have failed to demonstrate any significant association between QTd and autonomic dysfunction in multivariate analysis. 25 QT interval and hyperglycaemia in diabetes The reasons for QT abnormalities in diabetes are not complete- VOLUME 4 ISSUE 3. MAY/JUNE
3 ly understood. Does uncontrolled hyperglycaemia per se contribute to QT prolongation and increased QTd? In a study of healthy non-diabetic subjects, an independent association between high plasma glucose concentration and increased QTc duration and QTd was reported. 33 It was further shown in the same study that inhibition of glucose induced insulin release, by octerotide infusion during a hyperglycaemic clamp, did not influence ECG changes, suggesting that insulin does not play a major role in glucose induced ECG changes. A similar relation was observed between QTc duration and fasting glucose in a large population based study of more than 6,500 patients. 34 QT interval duration was found to be independently associated with HbA 1C in type 1 diabetes in the EURODIAB IDDM Complication Study. 23 In several studies in type 1 diabetes 18 and type 2 diabetes, 19,25 QT abnormalities were not influenced by the level of metabolic control (HbA 1C ) or duration of diabetes. In another study, mean HbA 1C was significantly greater for those with a QTc in the upper tertile compared to the lower tertile among adults with diabetes (8.0% vs. 7.5%, p<0.05) and impaired fasting glucose (5.7% vs. 5.4%, p<0.05), but there was no difference among adults with normal glucose. 35 A possible influence of hyperglycaemia on QT abnormalities can not be excluded and is worthy of further research. It has been proposed that hyperglycaemia may produce ventricular instability by increased sympathetic activity, increased cytosolic calcium content in myocytes or both. 36 Insulin stimulates sympathetic activity and diabetes is known to be associated with impaired parasympathetic cardiac control. This is reflected in a reduced ability to regulate heart rate as well as a reduction in heart rate variability. 37 QT interval and macrovascular risk in diabetes In the United Kingdom Prospective Diabetes Study (UKPDS), which enrolled adults with newly diagnosed type 2 diabetes, a significant reduction in all microvascular end points was noted in the intensive treatment group compared to the standard treatment group while a trend toward a reduction in cardiovascular outcomes was not statistically significant (p=0.052). 38 However, it has been shown in an epidemiological analysis of a UKPDS cohort that, for every 1% reduction in HbA 1C, there was an approximately 14% reduction of all cause mortality and MI, an effect which was statistically significant. 39 A systematic review after analysing data from six randomised controlled trials comparing conventional treatment with intensive insulin therapy noted a moderate treatment effect of glycaemic control on macrovascular events in type 1 diabetes. 40 Improving metabolic control, including glycaemia substantially reduces the burden of cardiovascular disease in diabetes. The mechanism by which prolonged QT interval and increased QTd predict increased cardiac mortality and morbidity in diabetes has been much debated. It appears that these two parameters provide different information. QTd is believed to correlate to a greater extent with the risk of ventricular arrhythmias than QT prolongation. Some conditions associated with a prolonged QT interval, e.g. therapy with sotalol may actually reduce the risk of sudden death in association with a reduction in QTd but an increase in QTc. 41 It was initially thought that this is because QTd reflects electrical heterogeneity, but this view has now been challenged and QTd has been proposed as a non-invasive marker of potentially lethal underlying cardiac abnormalities the most important being ischaemia. 42 It is further supported by the observation that QTd is prolonged immediately after an MI and tends to reduce after successful thrombolysis. 15 Overall, increased QTd seems to represent the sum of several adverse cardiac abnormalities such as fibrosis, hypertrophy, dilatation, ischaemia and probably, autonomic dysfunction. 27,42 All these factors individually confer increased cardiovascular risk and QTd, as a summation, could be a global prognostic marker for cardiac mortality in patients with diabetes. The debate on what causes sudden death arrhythmia or ischaemia continues. It has been suggested that a patient with QT abnormalities should undergo tests for myocardial ischaemia (treadmill test) as well as left ventricular abnormalities (echocardiogram). 42 Further directions Most of the studies of QT abnormalities in diabetes are observational and there is a marked paucity of interventional studies. There is a wealth of data to link QT abnormalities with cardiac ischaemia, but these abnormalities have been found even in newly diagnosed diabetic patients with no apparent cardiac disease. Despite an extensive literature search, no study was found that has assessed the effect, if any, of controlling hyperglycaemia on QTd and QT prolongation in patients with diabetes. It will be of interest to know if these QT abnormalities can be ameliorated by successful control of hyperglycaemia in diabetic patients without cardiovascular complications. However, improved glycaemic control will need to be achieved by diet or by drugs that do not by themselves affect QT interval (e.g. metformin, insulin). It has been recently shown in a small study that glibenclamide, a commonly used second-generation sulphonylurea, causes an increased QTc and QTd. 43 However, larger studies are needed to clarify this further. Increased QTd could possibly be used to identify a subgroup of diabetic patients which is at a particularly high risk of adverse cardiovascular outcome. Patients with this QT abnormality could be targeted for more detailed cardiac investigations, including a treadmill test, echocardiogram and angiography. If other structural or functional cardiac abnormalities are identified, specific therapeutic efforts, e.g. aggressive lowering of blood pressure etc. may be undertaken in an attempt to alter the outcome favourably. Despite the problems inherent in the accuracy and reproducibility of QT measurements, the greatest advantage of using the QT interval as a screening test is that it does not require patient compliance, is non-invasive, easily obtained and cost effective. However, it remains to be seen if more aggressive control of hyperglycaemia in this subgroup will help in improving QT 148 THE BRITISH JOURNAL OF DIABETES AND VASCULAR DISEASE
4 Key messages QT abnormalities predict cardiac death in several medical conditions including diabetes. Increased QTd is probably more predictive of ventricular arrhythmia and mortality than QT prolongation Standardisation of assessment of QTd is necessary, although some consider that the measure itself is an artefact QT interval is affected by cardiac ischaemia and autonomic neuropathy but the influence of hyperglycaemia is uncertain Increased QTd could be used as a cost effective marker to identify diabetic patients at high risk of cardiovascular morbidity and mortality abnormalities (i.e. ventricular instability) and, therefore, cardiac outcome. More long-term interventional studies are needed to shed light on this issue. References 1. Bazett HC. An Analysis of the time relations of electrocardiograms. Heart 1920;7: Hodges M, Salerno Q, Erlien D. Bazett s QT correction reviewed. Evidence that a linear QT correction for heart rate is better. J Am Coll Cardiol 1983;1: Macfarlane PW, Lawrie TDV. The normal electrocardiogram and vectorcardiogram. In: Macfarlane PW, Lawrie TDV, eds. Comprehensive Electrocardiology. Oxford, UK. Pergamon Press; 1989;1: Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation 1991;83: Ahnve S, Gilpin E, Madsen EB et al. Prognostic importance of QTc interval at discharge after acute myocardial infarction: a multicenter study of 865 patients. Am Heart J 1984;108: Jackman WM, Friday KJ, Anderson JL et al. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988;31: Day CP, McComb JM, Campbell RW. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990;63: Macfarlane PW, McLaughlin SC, Rodger JC. Influence of lead selection and population on automated measurement of QT dispersion. Circulation 1998;98: Barr CS, Nass A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994; 343: Darbar D, Luck J, Davidson N, Pringle T, Main G, McNeill G, Struthers AD. Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. BMJ 1996;312: Clarkson PB, Naas AA, McMahon A, MacLeod C, Struthers AD, MacDonald TM. QT dispersion in essential hypertension. QJM 1995; 88: Bujag G, Miorelli M, Turrini P, Melacini P, Nova A. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 1993; 72: Glancy JM, Garratt CJ, Woods KL. QT dispersion and mortality after myocardial infarction. Lancet 1995;345: Elming H, Holm E, Jun L et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 1998;19: Moreno FL, Villanueva MT, Karagounis LA for the TEAM-2 Investigators. A reduction in QT interval dispersion by successful thrombolytic therapy in acute MI. Circulation 1994;90: Zabel M, Portnoy S, Franz MR. Electrocardiographic indexes of dispersion of ventricular repolarization; an isolated heart validation study. J Am Coll Cardiol 1995;25: Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000;36: Veglio M, Giunti S, Stevens LK et al. Prevalence of Q-T Interval Dispersion in Type 1 Diabetes and Its Relation with Cardiac Ischaemia: the EURODIAB IDDM Complications Study Group. Diabetes Care 2002;25: Veglio M, Bruno G, Borra M et al. Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. J Inter Med 2002;25: Glancey MJ, Weston PJ, Bhullar HK et al. Reproducibility and automatic measurement of QT dispersion. Eur Heart J 1996;17: Rautaharju PM. QT and Dispersion of Ventricular Repolarization: The Greatest Fallacy in Electrocardiography in the 1990s. Circulation 1999; 99: Rautaharju PM. Why did QT dispersion die? Cardiac Electrophysiology Review 2002;6: Veglio M, Borra M, Stevens LK et al. The relationship between QTc interval prolongation and diabetic complications: the EURODIAB IDDM Complication Study Group. Diabetologia 1999;42: Sivieri R, Veglio M, Chinaglia A et al. Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. Diabetic Med 1993;10: Cardoso C, Salles G, Bloch K et al. Clinical determinants of increased QT dispersion in patients with diabetes mellitus. Intern J Cardiol 2001;79: Sawicki PT, Meinhold J, Kiwitt S et al. QT interval dispersion is an important predictor of mortality in NIDDM patients. Diabetes 1996;45: Naas AA, Davidson NC, Thompson C, Jung RT, Newton RW, Struthers AD. QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin-dependent diabetes: cohort study. BMJ 1998;316: Dinneen SF, Gerstein HC. The Association of Microalbuminuria and Mortality in Non-Insulin-Dependent Diabetes Mellitus: A Systematic Overview of the Literature. Arch Intern Med 1997;157: Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985;8: Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy: American Diabetes Association and American Academy of Neurology (Consensus Statement). Diabetes Care 1988;11: Whitsel EA, Boyko EJ, Siscovick DS. Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a metaanalysis. Diabetes Care 2000;23: Bravenboer B, Hendriksen PH, Oey LP et al. Is the corrected QT interval a reliable indicator of the severity of diabetic autonomic neuropathy? Diabetes Care 1993;16: Marfella R, Nappo F, DeAngelis L et al. The effect of acute hyperglycaemia on QTc duration in healthy men. Diabetologia 2000;43: Lefrandt JD, Diercks GFH, van Boven AJ et al. High fasting glucose and QTc duration in a large healthy cohort. Diabetologia 2000;43: Brown DW, Giles WH, Greenlund KJ et al. Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated VOLUME 4 ISSUE 3. MAY/JUNE
5 with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk 2001;8: Marfella R, Rossi F, Giugliano D. Hyperglycaemia and QT interval: time for re-evaluation. Diabetes Nutri Metab 2001;14: Julu P. Vagolytic effect of diabetes mellitus. Brain 1993;116: UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes [UKPDS 35]: prospective observational study. BMJ 2000;321: Lawson ML, Gerstein HC, Tsui E et al. Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. Diabetes Care 1999;22:B35-B Day CP, McComb JM, Matthews J et al. Reduction in QT dispersion by sotalol following myocardial infarction. Eur Heart J 1991;12: Rana BS, Band MM, Ogston S, Morris AD, Pringle SD, Struthers AD. Relation of QT interval dispersion to the number of different cardiac abnormalities in diabetes mellitus. Am J Cardiol 2002;90: Najeed SA, Khan IA, Molnar J et al. Differential effect of glyburide (glibenclamide) and metformin on QT dispersion: a potential adenosine triphosphate sensitive K+ channel effect. Am J Cardiol 2002;90: We are pleased to invite you to attend the 2nd Annual World Congress on the Insulin Resistance Syndrome 18th 20th November 2004, Hilton Universal City, Los Angeles, California, USA Insulin Resistance - One defect, many manifestations Clinical manifestations of the Insulin Resistance Syndrome and its relation to etiology, ethnicity, and epidemiology of: obesity, dyslipidaemia, cardiovascular disease, hypertension, PCOS, gestational diabetes, liver disease (NAFLD), cancer, inflammation and endothelial dysfunction, sleep apnoea and mood disorders in childhood, adolescence and adulthood. This is an excellent opportunity to network with faculty speakers from North America, Europe, and the Far East. Further information about this event is available at: Call for Abstracts Abstract Deadline 3rd September 2004 We welcome your submission of an abstract This is a CME activity Physicians Nurses Pharmacists Physician's Assistants Plenary Sessions Symposia Meet the Professor Workshops Exhibitions Registration: Early registration is $175 There is a bonus if you register before 15th May 2004: two free passes to the "Meet the Professor" luncheon For information on Registration Accommodation and Exhibits Tel: (818) Fax: (818) insulinresistance@pacbell.net Clark Street #212 Tarzana, CA *Co-sponsors & participating organisation: American Association of Clinical Endocrinologists Androgen Excess Society European Group for the Research of Obesity Hypertension and Insulin Resistance International Academy of Cardiology American Heart Association Council of Nutrition, Physical Activity and Metabolism *Members of the organisations will receive 30% discount in registration Hope to see you in November! 150 THE BRITISH JOURNAL OF DIABETES AND VASCULAR DISEASE
I n patients who have a stroke, the initial stroke is the main
377 CARDIOVASCULAR MEDICINE Long QTc predicts future cardiac death in stroke survivors K Y K Wong, R S Mac Walter, D Douglas, H W Fraser, S A Ogston, A D Struthers... See end of article for authors affiliations...
More informationDeclaration of conflict of interest. None to declare
Declaration of conflict of interest None to declare Risk management of coronary artery disease Arrhythmias and diabetes Hercules Mavrakis Cardiology Department Heraklion University Hospital Crete, Greece
More informationWhy is Earlier and More Aggressive Treatment of T2 Diabetes Better?
Blood glucose (mmol/l) Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Disclosures Dr Kennedy has provided CME, been on advisory boards or received travel or conference support from:
More informationCME Article Brugada pattern masking anterior myocardial infarction
Electrocardiography Series Singapore Med J 2011; 52(9) : 647 CME Article Brugada pattern masking anterior myocardial infarction Seow S C, Omar A R, Hong E C T Cardiology Department, National University
More informationQT Dispersion in Acute Myocardial Infarction with Special Reference to Left Ventriculographic Findings
QT Dispersion in Acute Myocardial Infarction with Special Reference to Left Ventriculographic Findings Yoshitaka DOI, M.D., Kazuyuki TAKADA, M.D., Hiroyuki MIHARA, M.D., Tomoki KAWANO, M.D., Osamu NAKAGAKI,
More informationErrors in manual measurement of QT intervals
386 Br Heart_J 1994;71:386-390 MEASUREMENT Regional Medical Physics Department, Freeman Hospital, Newcastle upon Tyne A Murray N B McLaughlin Academic Cardiology Department, Freeman Hospital, Newcastle
More informationREVIEW ARTICLE. Prolonged QTc Interval and Risks of Total and Cardiovascular Mortality and Sudden Death in the General Population
REVIEW ARTICLE Prolonged QTc Interval and Risks of Total and Cardiovascular and Sudden Death in the General Population A Review and Qualitative Overview of the Prospective Cohort Studies Alicia Montanez,
More informationThe relationship between blood glucose level and QTc duration in the critically ill
Bond University From the SelectedWorks of Gerben Keijzers March, 2009 The relationship between blood glucose level and QTc duration in the critically ill Ellen Burkett Gerben Keijzers James Lind Available
More informationMetformin should be considered in all patients with type 2 diabetes unless contra-indicated
November 2001 N P S National Prescribing Service Limited PPR fifteen Prescribing Practice Review PPR Managing type 2 diabetes For General Practice Key messages Metformin should be considered in all patients
More informationQT Interval: The Proper Measurement Techniques.
In the name of God Shiraz E-Medical Journal Vol. 11, No. 2, April 2010 http://semj.sums.ac.ir/vol11/apr2010/88044.htm QT Interval: The Proper Measurement Techniques. Basamad Z*. * Assistant Professor,
More informationDiploma in Electrocardiography
The Society for Cardiological Science and Technology Diploma in Electrocardiography The Society makes this award to candidates who can demonstrate the ability to accurately record a resting 12-lead electrocardiogram
More informationRisk Factors for Ischemic Stroke: Electrocardiographic Findings
Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead
More informationJournal of Internal Medicine 2002; 251:
Journal of Internal Medicine 2002; 251: 317 324 Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based
More informationThe interpretation of ECG in the young and in athletes.
PRACTICAL ECG COURSE The interpretation of ECG in the young and in athletes. Synopsis and aims: the practical ECG course is focused on ECG interpretation in young individuals (14-35 years) and in athletes.
More informationClinico-demographic profile of type 2 diabetes patients with cardiac autonomic neuropathy
Original Research Article Clinico-demographic profile of type 2 diabetes patients with cardiac autonomic neuropathy Kothai G 1, Prasanna Karthik S 2* 1 Assistant Professor, Department of General Medicine,
More information20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney disease CKD Brugada 5 Brugada Brugada 1
Symposium 39 45 1 1 2005 2008 108000 59000 55 1 3 0.045 1 1 90 95 5 10 60 30 Brugada 5 Brugada 80 15 Brugada 1 80 20 2 12 X 2 1 1 brain natriuretic peptide BNP 20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney
More informationCardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center
Cardiovascular Disease in CKD Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Describe prevalence for cardiovascular disease in CKD
More informationThe problem of uncontrolled hypertension
(2002) 16, S3 S8 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh The problem of uncontrolled hypertension Department of Public Health and Clinical Medicine, Norrlands
More informationA nationwide population-based study. Pai-Feng Hsu M.D. Shao-Yuan Chuang PhD
The Association of Clinical Symptomatic Hypoglycemia with Cardiovascular Events and Total Death in Type 2 Diabetes Mellitus A nationwide population-based study Pai-Feng Hsu M.D. Shao-Yuan Chuang PhD Taipei
More informationThe United Kingdom Prospective
Professional issues The UKPDS: a nursing perspective Marilyn Gallichan Article points 1The UKPDS followed up more than 5000 patients from 23 centres for a median of 10 years. 2The findings provide a powerful
More informationThe interpretation of ECG in the young and in athletes.
PRACTICAL ECG COURSE The interpretation of ECG in the young and in athletes. Synopsis and aims: the practical ECG course is focused on ECG interpretation in young individuals (14-35 years) and in athletes.
More informationNoninvasive Predictors of Sudden Cardiac Death
2011 년순환기관련학회춘계통합학술대회 Noninvasive Predictors of Sudden Cardiac Death 영남대학교의과대학순환기내과학교실신동구 Diseases associated with SCD Previous SCD event Prior episode of ventricular tachyarrhythmia Previous myocardial
More informationThe Relationship between Coronary Artery Aneurysm and QT Interval Dispersion in Acute Phase of Kawasaki Disease
Original Article Iran J Pediatr Jun 2011; Vol 21 (No 2), Pp: 220-224 The Relationship between Coronary Artery Aneurysm and QT Interval Dispersion in Acute Phase of Kawasaki Disease Abdolrazagh Kiani 1,
More information4/14/15. The Electrocardiogram. In jeopardy more than a century after its introduction by Willem Einthoven? Time for a revival. by Hein J.
The Electrocardiogram. In jeopardy more than a century after its introduction by Willem Einthoven? Time for a revival. by Hein J. Wellens MD 1 Einthoven, 1905 The ECG! Everywhere available! Easy and rapid
More informationGlucose and CV disease
Glucose and CV disease Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any means graphic, electronic,
More informationSupplementary webappendix
Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Ray K K, Seshasai S R K, Wijesuriya S,
More informationDiabetes: Staying Two Steps Ahead. The prevalence of diabetes is increasing. What causes Type 2 diabetes?
Focus on CME at the University of University Manitoba of Manitoba : Staying Two Steps Ahead By Shagufta Khan, MD; and Liam J. Murphy, MD The prevalence of diabetes is increasing worldwide and will double
More informationDiabetes Mellitus Type 2 Evidence-Based Drivers
This module is supported by an unrestricted educational grant by Aventis Pharmaceuticals Education Center. Copyright 2003 1 Diabetes Mellitus Type 2 Evidence-Based Drivers Driver One: Reducing blood glucose
More informationDiabetes and the Heart
Diabetes and the Heart By Samir Naim Assaad, MD, MRCP(UK), FRCP(Edin), FRCP(Lond) Professor of Medicine & Endocrinology University of Alexandria EGYPT Disclosure None, related to this presentation Road
More informationKidney and heart: dangerous liaisons. Luis M. RUILOPE (Madrid, Spain)
Kidney and heart: dangerous liaisons Luis M. RUILOPE (Madrid, Spain) Type 2 diabetes and renal disease: impact on cardiovascular outcomes The "heavyweights" of modifiable CVD risk factors Hypertension
More informationHyperglycemia in ACS. Dr. Imhemed Eljazwi
Hyperglycemia in ACS 2012-5-8 Dr. Imhemed Eljazwi Percentage of Population (n = 1181) Prevalence of Hyperglycemia in 181 Cardiac Patients Without Known Diabetes 100% 75% 50% 66% of AMI patients have
More informationStudy of relationship between QTC prolongation and cardiac autonomic neuropathy in Diabetes mellitus
Original Article Study of relationship between QTC prolongation and cardiac autonomic neuropathy in Diabetes mellitus N Natarajan, M S Ramaiyah, Associate Professor, Department of General Medicine, Kerala
More informationManagement of new-onset AF: Initial rate control treatment
Geneva Acute Crdiovascular Care Congress 2014 - October 18-20, 2014 Management of new-onset AF: Initial rate control treatment Antonio Raviele, MD, FESC, FHRS ALFA Alliance to Fight Atrial fibrillation,
More information1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and
1 The clinical syndrome of heart failure in adults is commonly associated with the etiologies of ischemic and non-ischemic dilated cardiomyopathy, hypertrophic cardiomyopathy, hypertensive heart disease,
More informationQT c interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up
Diabetologia (2007) 50:186 194 DOI 10.1007/s00125-006-0483-1 ARTICLE QT c interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up
More informationPreoperative tests (update)
National Institute for Health and Care Excellence. Preoperative tests (update) Routine preoperative tests for elective surgery NICE guideline NG45 Appendix C: April 2016 Developed by the National Guideline
More informationChanges in QTc Interval and QT Dispersion due to Incremental Atrial Pacing in Patients with Ventricular Tachyarrhythmia
Showa Univ J Med Sci 14(4), 271-279, December 2002 Original Changes in QTc Interval and QT Dispersion due to Incremental Atrial Pacing in Patients with Ventricular Tachyarrhythmia Taro ADACHI, Youlchl
More informationClinical Policy: Holter Monitors Reference Number: CP.MP.113
Clinical Policy: Reference Number: CP.MP.113 Effective Date: 05/18 Last Review Date: 04/18 Coding Implications Revision Log Description Ambulatory electrocardiogram (ECG) monitoring provides a view of
More informationSudden Cardiac Death in Sports: Causes and Current Screening Recommendations
Sports Cardiology Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Domenico Corrado, MD, PhD Inherited Arrhytmogenic Cardiomyopathy Unit Department of Cardiac, Thoracic and
More informationAre there low risk patients in Brugada syndrome?
Are there low risk patients in Brugada syndrome? Pedro Brugada MD, PhD Andrea Sarkozy MD Risk stratification in Brugada syndrome In the last years risk stratification in Brugada syndrome has become the
More informationJ-wave syndromes: update on ventricular fibrillation mechanisms
J-wave syndromes: update on ventricular fibrillation mechanisms Michael Nabauer University of Munich, Germany 28.8.2011 I have no conflicts of interest ECG labelling by Einthoven Circ 1998 Osborn wave
More informationClassification of electrocardiographic ST-T segments human expert vs artificial neural network
European Heart Journal (1993) 14,464-468 Classification of electrocardiographic ST-T segments human expert vs artificial neural network L. EDENBRANDT, B. DEVINE AND P. W. MACFARLANE University Department
More informationHEART CONDITIONS IN SPORT
HEART CONDITIONS IN SPORT Dr. Anita Green CHD Risk Factors Smoking Hyperlipidaemia Hypertension Obesity Physical Inactivity Diabetes Risks are cumulative (multiplicative) Lifestyles predispose to RF One
More informationRikshospitalet, University of Oslo
Rikshospitalet, University of Oslo Preventing heart failure by preventing coronary artery disease progression European Society of Cardiology Dyslipidemia 29.08.2010 Objectives The trends in cardiovascular
More informationQT Dispersion and T-Loop Morphology in Late Pregnancy and After Delivery
Physiol. Res. 51: 121-129, 2002 QT Dispersion and T-Loop Morphology in Late Pregnancy and After Delivery M. LECHMANOVÁ, O. KITTNAR, M. MLČEK, J. SLAVÍČEK, A. DOHNALOVÁ, Š. HAVRÁNEK, J. KOLAŘÍK, A. PAŘÍZEK
More informationArrhythmias Focused Review. Who Needs An ICD?
Who Needs An ICD? Cesar Alberte, MD, Douglas P. Zipes, MD, Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN Sudden cardiac arrest is one of the most common causes
More informationPresenter Disclosure Information
Various Morphological Types of Ventricular Premature Beats with Fragmented QRS Waves on 12 Lead Holter ECG had a Positive Relationship with Left Ventricular Fibrosis on CT in Patients with Hypertrophic
More informationGlucose Control: Does it lower CV risk?
Glucose Control: Does it lower CV risk? Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any means graphic,
More informationQUESTION: In a patient with different QT intervals, which one will give the highest prognostic accuracy? REPLY:
QUESTION: In a patient with different QT intervals, which one will give the highest prognostic accuracy? REPLY: First, there are two possibilities: I) It is not known, if the patient (subject) presented
More informationEugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG
Diabetes Mellitus: Update 7 What is the unifying basis of this vascular disease? Eugene J. Barrett, MD, PhD Professor of Internal Medicine and Pediatrics Director, Diabetes Center and GCRC Health System
More informationJournal of Clinical and Basic Cardiology
Journal of Clinical and Basic Cardiology An Independent International Scientific Journal Journal of Clinical and Basic Cardiology 1999; 2 (1), 22-33 Prognosis and treatment of cardiovascular disease in
More informationInter-regional differences and outcome in unstable angina
European Heart Journal (2000) 21, 1433 1439 doi:10.1053/euhj.1999.1983, available online at http://www.idealibrary.com on Inter-regional differences and outcome in unstable angina Analysis of the International
More informationRESUME Sep National Medical License, Taiwan Oct Board of Interal Medicine, Taiwan Aug Board of Cardiology, Internal Medicine, Taiwan
RESUME Ye-Hsu Lu, M.D. Office Address: No.100, Ziyou 1st Rd., Sanmin Dist., Kaohsiung City 80708, Taiwan TEL: +886-7-3121101 ext. 7741 (Office), +886-918867017 (Cell) FAX: +886-7-3234845 E-mail: yehslu@gmail.com
More informationMetformin. Sulfonylurea. Thiazolidinedione. Insulin
동아의대내분비내과박미경 Metformin Sulfonylurea Thiazolidinedione Insulin 요약 markers of inflammation (hs-crp, TNF-a) markers of impaired endothelial function (VFW, scams, tpa, PAI-1) LDL-C, fasting and postprandial
More informationThe Immediate Reproducibility of T Wave Alternans During Bicycle Exercise
Reprinted with permission from JOURNAL OF PACING AND CLINICAL ELECTROPHYSIOLOGY, Volume 25, No. 8, August 2002 Copyright 2002 by Futura Publishing Company, Inc., Armonk, NY 10504-0418. The Immediate Reproducibility
More informationSummary HTA. HTA-Report Summary
Summary HTA HTA-Report Summary Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events Schnell-Inderst
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationCharacteristics of the atrial repolarization phase of the ECG in paroxysmal atrial fibrillation patients and controls
672 Acta Cardiol 2015; 70(6): 672-677 doi: 10.2143/AC.70.6.3120179 [ Original article ] Characteristics of the atrial repolarization phase of the ECG in paroxysmal atrial fibrillation patients and controls
More informationSummary, conclusions and future perspectives
Summary, conclusions and future perspectives Summary The general introduction (Chapter 1) of this thesis describes aspects of sudden cardiac death (SCD), ventricular arrhythmias, substrates for ventricular
More informationMetabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic
More informationQT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy
European Heart Journal (1996) 17, 258-263 QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy L. Fei, J. H. Goldman,
More informationCedars Sinai Diabetes. Michael A. Weber
Cedars Sinai Diabetes Michael A. Weber Speaker Disclosures I disclose that I am a Consultant for: Ablative Solutions, Boston Scientific, Boehringer Ingelheim, Eli Lilly, Forest, Medtronics, Novartis, ReCor
More informationPacing in Drug Testing
ISHNE International Society for Holter and Noninvasive Electrocardiology 1 st Worldwide Internet Symposium on Drug- Induced QT Prolongation October 1-15, 1 15, 2007 Pacing in Drug Testing I Savelieva,
More informationThe value of the coefficient of variation in assessing repeat variation in ECG measurements
European Heart Journal (1998) 19, 342 351 The value of the coefficient of variation in assessing repeat variation in ECG measurements S. C. McLaughlin*, T. C. Aitchison and P. W. Macfarlane* *Department
More informationFurther insights into inheritable arrhythmia syndromes: Focus on electrocardiograms Postema, P.G.
UvA-DARE (Digital Academic Repository) Further insights into inheritable arrhythmia syndromes: Focus on electrocardiograms Postema, P.G. Link to publication Citation for published version (APA): Postema,
More informationAbnormal ECG patterns and significance in a group of mountaineers
Original Article Abnormal ECG patterns and significance in a group of mountaineers Wg Cdr V Vasdev*, Wg Cdr DS Chadha +, Gp Capt P Kharbanda #, Lt Col SK Datta**, Air Cmde RK Ganjoo AVSM VSM ++ ABSTRACT
More informationLong-Term Outcome Associated with Early Repolarization on Electrocardiography
original article Long-Term Outcome Associated with Early Repolarization on Electrocardiography Jani T. Tikkanen, B.S., Olli Anttonen, M.D., M. Juhani Junttila, M.D., Aapo L. Aro, M.D., Tuomas Kerola, M.D.,
More informationelectrocardiograms Analysis of emergency department interpretation of
Journal of Accident and Emergency Medicine 1994 11, 149-153 Correspondence: E.R. Snoey, Department of Emergency Medicine, Highland General Hospital 1411 East 31st Street, Oakland, California 94602, USA
More informationThe pill-in-the-pocket strategy for paroxysmal atrial fibrillation
The pill-in-the-pocket strategy for paroxysmal atrial fibrillation KONSTANTINOS P. LETSAS, MD, FEHRA LABORATORY OF CARDIAC ELECTROPHYSIOLOGY EVANGELISMOS GENERAL HOSPITAL OF ATHENS ARRHYTHMIAS UPDATE,
More informationPatient referral for elective coronary angiography: challenging the current strategy
Patient referral for elective coronary angiography: challenging the current strategy M. Santos, A. Ferreira, A. P. Sousa, J. Brito, R. Calé, L. Raposo, P. Gonçalves, R. Teles, M. Almeida, M. Mendes Cardiology
More informationLIST OF ABBREVIATIONS
Diabetes & Endocrinology 2005 Royal College of Physicians of Edinburgh Diabetes and lipids 1 G Marshall, 2 M Fisher 1 Research Fellow, Department of Cardiology, Glasgow Royal Infirmary, Glasgow, Scotland,
More information3. NEW DIAGNOSTIC CRITERIA, NEW CLASSIFICATION OF DM AND MODERN THERAPY APPROACH
3. NEW DIAGNOSTIC CRITERIA, NEW CLASSIFICATION OF DM AND MODERN THERAPY APPROACH 1.1 Introduction Ivana Pavlić-Renar, Ph.D. Vuk Vrhovac University Clinic, Zagreb, Croatia The current classification of
More informationThe Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia
The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia By Sandeep Joshi, MD and Jonathan S. Steinberg, MD Arrhythmia Service, Division of Cardiology
More informationDICE Study Backgrounder
DICE Study Backgrounder Diabetes In Canada Evaluation (DICE), the largest diabetes study of its kind in Canada, examines the management and control of type 2 diabetes in the Canadian family practice setting.
More informationThe Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More informationCardiac hypertrophy and how it may break an athlete s heart e the Cypriot case
Eur J Echocardiography (2005) 6, 301e307 Cardiac hypertrophy and how it may break an athlete s heart e the Cypriot case C.E. Chee a,1, C.P. Anastassiades a,1, A.G. Antonopoulos b, A.A. Petsas b, L.C. Anastassiades
More informationA NEW RISK FACTOR FOR EARLY HEART FAILURE: PRETERM BIRTH
A NEW RISK FACTOR FOR EARLY HEART FAILURE: PRETERM BIRTH 1* Paul Leeson, PhD, FRCP and 1 Adam J. Lewandowski, DPhil 1 Oxford Cardiovascular Clinical Research Facility, Division of Cardiovascular Medicine,
More informationCardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death
Cardiac Conditions in Sport & Exercise Dr Anita Green Cardiac Conditions in Sport Sudden Cardiac Death USA - Sudden Cardiac Death (SCD)
More informationMEDICAL POLICY POLICY TITLE T-WAVE ALTERNANS TESTING POLICY NUMBER MP
Original Issue Date (Created): August 23, 2002 Most Recent Review Date (Revised): September 24, 2013 Effective Date: November 1, 2013 I. POLICY T-wave alternans is considered investigational as a technique
More informationThe retinal renin-angiotensin system: implications for therapy in diabetic retinopathy
(2002) 16, S42 S46 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh : implications for therapy in diabetic retinopathy AK Sjølie 1 and N Chaturvedi 2 1 Department
More informationIMPACT OF AGE AND GENDER ON QTc INTERVAL- A RETROSPECTIVE STUDY
IMPACT OF AGE AND GENDER ON QTc INTERVAL- A RETROSPECTIVE STUDY *Nachal Annamalai 1, Revathi M 2, Alamelu Palaniappan 3 and Rajajeyakumar M 1 1 Department of Physiology, Chennai Medical College Hospital
More informationRisk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin
Diabetologia (2006) 49: 930 936 DOI 10.1007/s00125-006-0176-9 ARTICLE J. M. M. Evans. S. A. Ogston. A. Emslie-Smith. A. D. Morris Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes:
More informationDiabetic Neuropathy: Discordance between Symptoms and Electrophysiological Testing in Saudi Diabetics
Bahrain Medical Bulletin, Vol.24, No.1, March 2002 Diabetic Neuropathy: Discordance between Symptoms and Electrophysiological Testing in Saudi Diabetics Daad H Akbar, FRCP(UK), Arab Board, Saudi Board
More informationROLE OF THE SIGNAL ECG IN RISK STRATIFICATION OF SCD. An overview
ROLE OF THE SIGNAL ECG IN RISK STRATIFICATION OF SCD. An overview Nabil El-Sherif, MD SUNY - Downstate Medical Center & New York harbor VA Healthcare System Brooklyn, NY, USA Signal Averaged ECG: A Selective
More informationSevere hypoglycemia requiring medical assistance in patients with diabetes is associated with simultaneous prolongation of QTc interval
Severe hypoglycemia requiring medical assistance in patients with diabetes is associated with simultaneous prolongation of QTc interval M. Mylona¹, G. Anastasiadis², K. Zerva², V. Vasgiourakis², K. Tsakalis²,
More informationThe Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Update 2013 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine Denver Health
More informationUse of Signal Averaged ECG and Spectral Analysis of Heart Rate Variability in Antiarrhythmic Therapy of Patients with Ventricular Tachycardia
October 1999 513 Use of Signal Averaged ECG and Spectral Analysis of Heart Rate Variability in Antiarrhythmic Therapy of Patients with Ventricular Tachycardia G.M. KAMALOV, A.S. GALYAVICH, N.R. KHASSANOV,
More informationLong-term outcome after normal myocardial perfusion imaging in suspected ischaemic heart disease
Dan Med J 65/2 February 2018 DANISH MEDICAL JOURNAL 1 Long-term outcome after normal myocardial perfusion imaging in suspected ischaemic heart disease Pia Hedegaard Johnsen 1, Martin Berg Johansen 1, 2
More information폐동맥협착증에서풍선판막성형술후심실재분극의변화
Original Articles Korean Circulation J 2001;313:341-346 폐동맥협착증에서풍선판막성형술후심실재분극의변화 고재곤 윤소영 김영휘 박인숙 Changes in Ventricular Repolarization after Balloon Valvuloplasty in Patients with Pulmonary Stenosis Jae
More informationSCIENTIFIC STUDY REPORT
PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established
More informationHRV in Diabetes and Other Disorders
HRV in Diabetes and Other Disorders Roy Freeman, MD Center for Autonomic and Peripheral Nerve Disorders Beth Israel Deaconess Medical Center Harvard Medical School Control Propranolol Atropine Wheeler
More informationATEF ELBAHRY,FACA,FICA,MISCP,FVBWG.
Hyperglycemia and Coronary Events: where is the link? ATEF ELBAHRY,FACA,FICA,MISCP,FVBWG. Cardiovascular (CV) disease is the primary complication of diabetes ~65% of deaths are due to CV disease Coronary
More informationVentricular Arrhythmias in Acute MI Patients Undergoing Primary PCI
Ventricular Arrhythmias in Acute MI Patients Undergoing Primary PCI Bulent Gorenek MD FACC FESC Eskişehir Osmangazi University Cardiology Department Eskisehir-Turkey I do not have any potential conflict
More informationat least 4 8 hours per week
ECG IN ATHLETS An athlete is defined as an individual who engages in regular exercise or training for sport or general fitness, typically with a premium on performance, and often engaged in individual
More informationSriram Padmanabhan, MD, Helme Silvet, MD, Jatin Amin, MD, and Ramdas G. Pai, MD Loma Linda, Calif
Congestive Heart Failure Prognostic value of QT interval and QT dispersion in patients with left ventricular systolic dysfunction: Results from a cohort of 2265 patients with an ejection fraction of
More informationSignal-Averaged Electrocardiography (SAECG)
Medical Policy Manual Medicine, Policy No. 21 Signal-Averaged Electrocardiography (SAECG) Next Review: April 2018 Last Review: April 2017 Effective: May 1, 2017 IMPORTANT REMINDER Medical Policies are
More informationGuidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
More informationSyncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation?
Innovations in Interventional Cardiology and Electrophysiology Thessaloniki 2014 Syncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation? K. Letsas, MD, FESC
More informationDiabetes new challenges, new agents, new order
Diabetes new challenges, new agents, new order Ken Earle St Georges University Hospitals NHS Foundation Trust Overview Cardiovascular disease unmet needs Treating evident and residual risk Integrating
More informationDiabetes Day for Primary Care Clinicians Advances in Diabetes Care
Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:
More information